Warby Parker Inc.
NYSE:WRBYMedical - Instruments & Supplies
+$0.92 today
- Market cap
- $3.07B
- Beta
- 1.97
- P/E (TTM)
- 2305.1
- EPS (TTM)
- $0.01
Volume 5.90M
Average 2.81M
WRBY Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Warby Parker Inc.NYSE: WRBY
Accounts Payables · Q2 FY2026 · quarter ended Jun 2026
Accounts payables turns positive
Q2 FY2026 accounts payables was $4.49M, compared with -$2.78M a year earlier. Trailing-twelve-month accounts payables was $13.36M.
Context
- Accounts payables amounted to 1.0% of revenue in FY2025, up 0.9 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts payables holds near $4.49M or moves back toward the trailing-twelve-month quarterly average of $3.34M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 8.5M USD
- Year-over-year change
- +1133.7%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.5M | +1133.7% |
| FY2024 | 2024-12-31 | 689K | -57.8% |
| FY2023 | 2023-12-31 | 1.63M | +120.6% |
| FY2022 | 2022-12-31 | (7.94M) | +28.5% |
| FY2021 | 2021-12-31 | (11.11M) | — |
Accounts Payables vs competitors
How WRBY compares with its peers on the latest reported figures
- WRBY's LTM Jun 2026 accounts payables of $13.36M is the 5th largest of the 10 companies compared; the peer median is $3.04M.
- Its year-over-year change of +1061.1% is the 2nd highest of 10, against a peer median of -41.5%.
- Accounts payables amounts to 1.5% of revenue for WRBY, versus a peer median of 1.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $366.12M | -275.5% | +1.0% | 3.4% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $115.91M | +3623.5% | — | 5.0% |
| LTM Jun 2026 | $18.71M | +161.8% | — | 1.4% | |
| LTM Mar 2026 | $13.6M | +197.1% | +19.4% | 0.5% | |
| LTM Jun 2026 | $13.36M | +1061.1% | — | 1.5% | |
| LTM Jun 2026 | $12.29M | -170.3% | -42.8% | 0.6% | |
| LTM Mar 2026 | $7.12M | +319.4% | +86.7% | 2.8% | |
| LTM Jul 2026 | $6.54M | -46.1% | — | 0.4% | |
| LTM Jun 2026 | $3.04M | -41.5% | +36.5% | 1.9% | |
| LTM Mar 2026 | $1M | -108.3% | -28.4% | 0.0% | |
| Peer median (excluding WRBY) | $3.04M | -41.5% | +10.2% | 1.4% | |
Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (144.27M) | (110.39M) | (63.2M) | (20.39M) | 1.64M |
| Depreciation & Amortization | 21.87M | 31.86M | 38.55M | 45.87M | 50.28M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 107.15M | 98.03M | 70.51M | 47.29M | 34.54M |
| Change in Working Capital | (24.5M) | (14.55M) | 5.81M | 19.26M | 17.55M |
| Accounts Receivables | (392K) | (451K) | (345K) | (169K) | (1.34M) |
| Inventory | (18.62M) | (11.79M) | 6.61M | 9.89M | 7.83M |
| Accounts Payables | (11.11M) | (7.94M) | 1.63M | 689K | 8.5M |
| Other Working Capital | 5.63M | 5.64M | (2.09M) | 8.85M | 2.55M |
| Other Non-Cash Items | 7.76M | 5.42M | 9.32M | 6.72M | 6.78M |
| Operating Cash Flow | (31.99M) | 10.37M | 60.99M | 98.74M | 110.79M |
| Capital Expenditures | (48.51M) | (60.18M) | (53.67M) | (64.03M) | (67.05M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (1M) | (2M) | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (48.51M) | (60.18M) | (54.67M) | (66.03M) | (67.05M) |
| Debt Repayment | 31.61M | 91K | 0 | 0 | 0 |
| Common Stock Issued | 20.04M | 3.2M | 2.87M | 4.63M | 2.36M |
| Common Stock Repurchased | (8.09M) | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (20.56M) | 0 | 0 | 333K | (14.36M) |
| Financing Cash Flow | 23M | 3.29M | 2.87M | 4.96M | (12M) |
| Effect of Forex Changes | (161K) | (1.31M) | (882K) | (406K) | 457K |
| Net Change in Cash | (57.67M) | (47.83M) | 8.31M | 37.27M | 32.2M |
| Free Cash Flow | (80.51M) | (49.81M) | 7.32M | 34.71M | 43.74M |
Warby Parker Inc.
NYSE:WRBY
Intrinsic Alpha fair value
Locked
Current Price
$28.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.